This information is intended for healthcare professionals based in Ireland.
Click here for current Eliquis SmPC information

ELIQUIS in NVAF

ELIQUIS® is indicated in the prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation (NVAF).1

READ MORE
ELIQUIS in VTE Treatment & Prevention

ELIQUIS® is indicated for the treatment of DVT and PE, and the prevention of recurrent DVT and PE, in adults.1

READ MORE
ELIQUIS in VTE Prophylaxis

ELIQUIS® is indicated for the prevention of VTE in adult patients who have undergone elective hip or knee replacement surgery.1

READ MORE

Risk Minimisation Materials

The Eliquis (apixaban) Prescriber Guide and Patient Alert Card are risk minimisation materials developed for all indications as an aid to prescribing, in particular they are aimed at increasing awareness about the potential risk of bleeding during treatment with apixaban and providing guidance on how to manage that risk. Copies of these educational materials may be obtained by contacting the Bristol-Myers Squibb Medical Information Department (telephone: 1800 749 749; e-mail: medical.information@bms.com).

References:

  1. ELIQUIS® (apixaban) Summary of Product Characteristics, June 2014.